Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) ("Field
Trip"), a leader in the development and delivery of psychedelic
therapies, today announced it will participate in the H.C.
Wainwright 23rd Annual Global Investment Conference, the
Oppenheimer Fall Healthcare Life Sciences and MedTech Summit, the
Maxim Group Mental Health Conference and the Cantor Virtual Global
Health Conference in September 2021.
H.C. Wainwright
23rd Annual Global Investment
Conference: September
13th-15th
2021
Field Trip’s Co-founder and CEO, Joseph Del
Moral, and Field Trip’s Chief Scientific Officer, Dr. Nathan
Bryson, will participate in a Fireside Chat at the H.C. Wainwright
23rd Annual Global Investment Conference. The Fireside Chat will be
pre-recorded and will be accessible to those registered for the
conference from Monday, September 13th at 7:00am Eastern Time
through Wednesday, September 15th 2021.
Additionally, the Field Trip management team
will participate in virtual one-on-one meetings for the duration of
the conference. To schedule a meeting or to request further
information on the conference, please contact your H.C. Wainwright
representative or KCSA Strategic Communications at
fieldtripIR@kcsa.com.
Oppenheimer Fall Healthcare Life
Sciences and MedTech Summit: September
21st-23rd
2021
Field Trip’s Co-founder and CEO, Joseph Del
Moral, and Field Trip’s Chief Scientific Officer, Dr. Nathan
Bryson, will present at the Oppenheimer Fall Healthcare Life
Sciences and MedTech Summit at 2:55pm Eastern Time on Tuesday,
September 21st 2021.
The presentation will be webcast and available
through this link:
https://wsw.com/webcast/oppenheimer16/ftrp/2808276.
A recording of the presentation will be
accessible on the Field Trip website for 90 days in the Investor
Relations section under Events and Presentations.
To request a virtual one-on-one meeting with the
Field Trip management team, or for further information on the
conference, please contact your Oppenheimer representative or KCSA
Strategic Communications at fieldtripIR@kcsa.com.
Maxim Group Advances in Mental Health
Conference: September 22nd
2021
Field Trip’s Co-founder and CEO, Joseph Del
Moral, and Field Trip’s Chief Scientific Officer, Dr. Nathan
Bryson, will participate in Maxim Group’s Advances in Mental Health
Conference, which will be held virtually on Wednesday, September
22nd 2021. As part of the “Disruptors in the Mental Health Space”
virtual panel series, Field Trip will participate in the Next-Gen
Novel Chemical Entities and the Clinics and Commercialization
panels.
For more information about the conference, or to
request a one-on-one meeting with Field Trip management, please
contact your Maxim Group representative or KCSA Strategic
Communications at fieldtripIR@kcsa.com.
Cantor Virtual Global Health Conference:
September
27th-30th
2021Field Trip’s Co-founder and Executive
Chairman, Ronan Levy, and Field Trip’s Chief Scientific Officer,
Dr. Nathan Bryson, will present at the Cantor Virtual Global Health
Conference at 9:20am Eastern Time on Wednesday, September 29th
2021.
The presentation will be webcast and available
through this link:
https://wsw.com/webcast/cantor12/ftrp/2105880.
A recording of the presentation will be
accessible on the Field Trip website for 180 days in the Investor
Relations section under Events and Presentations.
The Field Trip management team will also be
participating in one-on-one meetings during the conference. To
schedule a meeting, or to request more information, please contact
your Cantor Fitzgerald representative or KCSA Strategic
Communications at fieldtripIR@kcsa.com.
About Field Trip Health Ltd.
Field Trip is a global leader in the development
and delivery of psychedelic therapies. With our Field Trip
Discovery division leading the development of the next generation
of psychedelic molecules and conducting advanced research on
plant-based psychedelics and our Field Trip Health division
building centers for psychedelic therapies opening across North
America and Europe along with the digital and technological tools
that will enable massive scale, we help people in need with a
simple, evidence-based way to heal and heighten engagement with the
world.
Learn more
at https://www.meetfieldtrip.com, https://www.fieldtriphealth.com
and https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram:
@fieldtriphealth.
To receive company updates about Field Trip and
to be added to the email distribution list please sign up here.
Cautionary Note Regarding
Forward-Looking Information
This release includes forward-looking
information (within the meaning of Canadian securities laws and
within the meaning of the United States Private Securities
Litigation Reform Act of 1995) regarding Field Trip and its
business. Often but not always, forward-looking information can be
identified by the use of words such as "expect", "intends",
"anticipated", "believes" or variations (including negative
variations) of such words and phrases, or state that certain
actions, events or results "may", "could", "would" or "will" be
taken, occur or be achieved. Such statements are based on the
current expectations and views of future events of the management
of Field Trip, and are based on assumptions and subject to risks
and uncertainties. Although the management of Field Trip believes
that the assumptions underlying these statements are reasonable,
they may prove to be incorrect. The forward-looking events and
circumstances discussed in this release may not occur and could
differ materially as a result of known and unknown risk factors and
uncertainties affecting the companies, including interest in the
training program, interest in the KAP Co-Op Program, uptake of the
KAP Co-Op Program by therapists and patients, the timing and
results of its research and development programs, approval of phase
1 human trials, if any, the risk that future clinical studies may
not proceed as expected or may produce unfavorable results, the
opening of additional clinics, the COVID-19 epidemic, the medical
clinic industry, market conditions, economic factors, management's
ability to manage and to operate the business and the equity
markets generally. Although Field Trip has attempted to identify
important factors that could cause actual actions, events or
results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. Accordingly, readers should not place undue
reliance on any forward-looking statements or information. No
forward-looking statement can be guaranteed. Except as required by
applicable securities laws, forward-looking statements speak only
as of the date on which they are made and Field Trip does not
undertake any obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future events, or otherwise.
This press release does not constitute an offer
to sell or the solicitation of an offer to buy securities.
Neither the Toronto Stock Exchange, nor its
Regulation Services Provider, have approved the contents of this
release or accept responsibility for the adequacy or accuracy of
this release.
Media contacts:Rachel MoskowitzAutumn
Communications202-276-7881press@fieldtriphealth.com
Nick Opich / McKenna MillerKCSA Strategic
Communications212-896-1206 /
347-487-6197press@fieldtriphealth.com
Investor contacts:Kathleen Heaney / Tim
ReganKCSA Strategic CommunicationsfieldtripIR@kcsa.com.
SOURCE Field Trip Health Ltd.
Field Trip Health (NASDAQ:FTRP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Field Trip Health (NASDAQ:FTRP)
Historical Stock Chart
From Apr 2023 to Apr 2024